Related references
Note: Only part of the references are listed.Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
Scott R. Daigle et al.
BLOOD (2013)
Conformational Adaptation Drives Potent, Selective and Durable Inhibition of the Human Protein Methyltransferase DOT1L
Aravind Basavapathruni et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2012)
Orphan drug development: an economically viable strategy for biopharma R&D
Kiran N. Meekings et al.
DRUG DISCOVERY TODAY (2012)
Chromatin modifications as therapeutic targets in MLL-rearranged leukemia
Aniruddha J. Deshpande et al.
TRENDS IN IMMUNOLOGY (2012)
DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis
Anh Tram Nguyen et al.
BLOOD (2011)
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Scott R. Daigle et al.
CANCER CELL (2011)
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Kathrin M. Bernt et al.
CANCER CELL (2011)
MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia
Sara C. Monroe et al.
EXPERIMENTAL HEMATOLOGY (2011)
Cancer genomics: from discovery science to personalized medicine
Lynda Chin et al.
NATURE MEDICINE (2011)
The US Orphan Drug Act: Rare disease research stimulator or commercial opportunity?
Olivier Wellman-Labadie et al.
HEALTH POLICY (2010)
AFF4, a Component of the ELL/P-TEFb Elongation Complex and a Shared Subunit of MLL Chimeras, Can Link Transcription Elongation to Leukemia
Chengqi Lin et al.
MOLECULAR CELL (2010)
Rare diseases, orphan drugs and their regulation: questions and misconceptions
Erik Tambuyzer
NATURE REVIEWS DRUG DISCOVERY (2010)
The molecular biology of mixed lineage leukemia
Robert K. Slany
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Misguided Transcriptional Elongation Causes Mixed Lineage Leukemia
Dorothee Mueller et al.
PLOS BIOLOGY (2009)
H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias
Andrei V. Krivtsov et al.
CANCER CELL (2008)
Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia
Matthew G. Guenther et al.
GENES & DEVELOPMENT (2008)
A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification
Dorothee Mueller et al.
BLOOD (2007)
MLL translocations, histone modifications and leukaemia stem-cell development
Andrei V. Krivtsov et al.
NATURE REVIEWS CANCER (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
MLL associates specifically with a subset of transcriptionally active target genes
TA Milne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
hDOT1L links histone methylation to leukemogenesis
Y Okada et al.
CELL (2005)
Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain
Q Feng et al.
CURRENT BIOLOGY (2002)
MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
SA Armstrong et al.
NATURE GENETICS (2002)
Share Paper
